Skip to content

Auricular Acupressure for Insomnia of Maintenance Hemodialysis Patients: a double blind, randomized, placebo controlled study

Auricular Acupressure for Insomnia of Maintenance Hemodialysis Patients: a double blind, randomized, placebo controlled study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002272
Enrollment
Unknown
Registered
2012-05-07
Start date
2012-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

treatment group:Auricular Acupressure on active acupoints
control group:sham Auricular Acupressure (on inactive acupoints)

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Subjects are selected MHD patients from local hemodialysis center who are dialyzed twice or three times a week (total treatment>=10 hours). Those meeting all of the following criteria are included: 1. Duration of dialysis ranging between 12 and 120 month; 2. Age 18~75 years; 3. Insomnia according to DSM-IV-TR; 4. Global score of PSQI >7; 5. Abstinence from hypnotics, or using a lowest maintaining dose of hypnotics(e.g. eszolam <=1mg/d), during the last three months; 6. Informed consent.

Exclusion criteria

Exclusion criteria: Patients with any of the following conditions are excluded: presence of concurrent affections (e.g. cancer, congestive heart failure, connective tissue disease, hematologic diseases) and of psychiatric disorders; inadequately dialyzed, indicating by urea clearance index (KT/V) lower than 1.20; presence of severe physical symptoms such as bone pain and itchy skin that are obviously causative for insomnia; and weary condition caused by severe anemia (hemoglobin<60g/L) or malnutrition (serum albumin<30g/L).

Design outcomes

Primary

MeasureTime frame
PSQ;

Secondary

MeasureTime frame
weekly amount of hypnotic;

Countries

China

Contacts

Public ContactXiuqing Wu
gzwuxiuqing@21cn.com+86 020 81887233-38501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026